How GLP-1 Receptor Agonists Can Help With Diabetes With that important disclosure out of the way, here are the most common diabetes-related benefits associated with Ozempic and potentially other GLP-1 receptor agonists
Top Weight Loss Medications
What Semaglutide Does Semaglutide is a GLP-1 receptor agonist, mimicking a hormone naturally released after eating
For example, manufacturer Novo Nordisks titration protocol for weekly Wegovy injections looks like: Weeks 1-4: 0.25mg Weeks 5-8: 0.5mg Weeks 9-12: 1mg Weeks 13-16: 1.7mg Week 17+: 2.4mg Despite this gradual increase, youre most likely to experience pronounced side effects early in semaglutide treatment as your body adjusts to the medication
Consequently, this triggers a significant reduction in appetite through the bodys innate insulin secretion
As weight loss drugs, semaglutide was approved as Wegovy in 2021 and tirzepatide was approved as Zepbound in 2023